BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information

This integration allows users to visualize and share plasmid information such as maps and sequences within the web-based CDD Vault application. Snap...

April 18, 2022 | News

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...

April 07, 2022 | News

CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs

Hasten fast-tracks transformative medicines for patients in China Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has ...

April 01, 2022 | News

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines

Daewoong Pharmaceutical (CEO Sengho Jeon & Changjae Lee) recently announced that it has submitted the New Drug Application (NDA) for a n...

March 29, 2022 | News

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...

March 25, 2022 | News

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced tha...

March 22, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

March 18, 2022 | News

Molecular Health collaborates to explore the molecular causation of adverse drug reactions

Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that d...

March 11, 2022 | News

Genome and Company announces Clinical Trial Collaboration with MSD

Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company, announced it has...

March 07, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

Cambrex Expands Biopharmaceutical Services Business

The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecul...

March 01, 2022 | News

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...

February 28, 2022 | News

HitGen , MTPC to discover novel hit compounds for multiple drug targets

During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...

February 25, 2022 | News

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

JAB-21822 in combination with cetuximab for the treatment of KRAS G12C-mutated advanced colorectal cancer. Colorectal cancer is the second most common tumo...

February 24, 2022 | News

Stay Connected